dream heightmaxxing stack

avenox

avenox

early bird gets the worm
Joined
Mar 2, 2025
Posts
13,492
Reputation
19,107
Idk if these are dangerous tigether ive dineno reasearch so put that into place

.infigratinib
.HGH
.Letrozole
.Abaloparatide
 
  • +1
Reactions: madnalyh, davidlaidisme67 and edcel
Idk if these are dangerous tigether ive dineno reasearch so put that into place

.infigratinib
.HGH
.Letrozole
.Abaloparatide
FGFR3 inhibition
GH/Igf-1 boosting
E2 inhibition
PTHrP increased

FGFR3 is a light break, it's not anything special like people make it seem like. Gigantism proves that.

The GH/IGF-1 boosts would be minor.

The E2 could be notable as higher E2 levels cause the PTHrP efficiency to go down causing cells to go from the proliferation phase -> hypertrophic phase meaning the total number of divisions would be lower. Higher E2 levels also cause the Runx2 & MEF2C to activate sooner, also causing it to lower height.

The PTH increase, making the PTHrP pathway increased, makes cells duplicate more before going into the other stages, this effectively gains chondrocyte efficiency as the deciding factor is the PTHrP:IHH ratio. You could also inhibit the IHH in some way but it's a bit more nuanced than that as it plays multiple roles.

You're still missing optimization of most pathways as there are 4 or 9 steps depending on how far you're willing to split it up. This mainly only targets the proliferation stage.

VEGF, IHH, Sclerostin inhibition, T3/T4 increases (needs to be increased if you run a stack optimizing every pathway, else lowering it a bit below baseline is theorized to increase height by myself), SOX9, and many more that I cannot be bothered to list.

To answer your question though, yes, they should work together and it's not very dangerous.
 
  • +1
  • Love it
Reactions: heinz_guderian, Apchun144, Framemaxxx and 1 other person
FGFR3 inhibition
GH/Igf-1 boosting
E2 inhibition
PTHrP increased

FGFR3 is a light break, it's not anything special like people make it seem like. Gigantism proves that.

The GH/IGF-1 boosts would be minor.

The E2 could be notable as higher E2 levels cause the PTHrP efficiency to go down causing cells to go from the proliferation phase -> hypertrophic phase meaning the total number of divisions would be lower. Higher E2 levels also cause the Runx2 & MEF2C to activate sooner, also causing it to lower height.

The PTH increase, making the PTHrP pathway increased, makes cells duplicate more before going into the other stages, this effectively gains chondrocyte efficiency as the deciding factor is the PTHrP:IHH ratio. You could also inhibit the IHH in some way but it's a bit more nuanced than that as it plays multiple roles.

You're still missing optimization of most pathways as there are 4 or 9 steps depending on how far you're willing to split it up. This mainly only targets the proliferation stage.

VEGF, IHH, Sclerostin inhibition, T3/T4 increases (needs to be increased if you run a stack optimizing every pathway, else lowering it a bit below baseline is theorized to increase height by myself), SOX9, and many more that I cannot be bothered to list.

To answer your question though, yes, they should work together and it's not very dangerous.

I have never loved a internet stranger as much as I am now in a non homosexual way, Thank you so much my nigga.
 
FGFR3 inhibition
GH/Igf-1 boosting
E2 inhibition
PTHrP increased

FGFR3 is a light break, it's not anything special like people make it seem like. Gigantism proves that.

The GH/IGF-1 boosts would be minor.

The E2 could be notable as higher E2 levels cause the PTHrP efficiency to go down causing cells to go from the proliferation phase -> hypertrophic phase meaning the total number of divisions would be lower. Higher E2 levels also cause the Runx2 & MEF2C to activate sooner, also causing it to lower height.

The PTH increase, making the PTHrP pathway increased, makes cells duplicate more before going into the other stages, this effectively gains chondrocyte efficiency as the deciding factor is the PTHrP:IHH ratio. You could also inhibit the IHH in some way but it's a bit more nuanced than that as it plays multiple roles.

You're still missing optimization of most pathways as there are 4 or 9 steps depending on how far you're willing to split it up. This mainly only targets the proliferation stage.

VEGF, IHH, Sclerostin inhibition, T3/T4 increases (needs to be increased if you run a stack optimizing every pathway, else lowering it a bit below baseline is theorized to increase height by myself), SOX9, and many more that I cannot be bothered to list.

To answer your question though, yes, they should work together and it's not very dangerous.

What if I add Test Propianate/Enathate into the stack?
 
  • +1
Reactions: Framemaxxx
Idk if these are dangerous tigether ive dineno reasearch so put that into place

.infigratinib
.HGH
.Letrozole
.Abaloparatide
Bro, you forgot drinking raw milk, and eating raw meat during development
 
  • JFL
Reactions: Framemaxxx and avenox
I do anastrozole and hgh only idk
I don’t think i could get any other stuff what is non popular amongst bodybuilders
 
  • +1
Reactions: avenox

Similar threads

J
Replies
22
Views
279
Sayan.xdd
Sayan.xdd
htntown
Replies
1
Views
43
htntown
htntown
the big L
Replies
13
Views
550
Squeakswashere
Squeakswashere
K
Replies
17
Views
196
Noriju
N

Users who are viewing this thread

Back
Top